Boston Scientific increased its annual profit forecast on Wednesday, fueled by strong demand for its cardiac implants, but temporarily halted a pivotal heart equipment study citing unexpected events.
Boston Scientific boosted its projection for 2024 sales growth, and is now targeting growth of 16.5%, compared with a previous estimate range between 13.5% and 14.5% from 2023 levels of $14.24 billion ...
Lockheed Martin raised full-year earnings guidance after sales increased and its backlog hit a new high last quarter. The world's biggest military contractor recorded lower sales in its aeronautics ...